Our results suggest that residual activity of CCNO or genetic modifiers in some of the RGMC patient alleles identified may explain the incomplete penetrance of hydrocephalus and that heterozygous alleles of CCNO may cause pathologies in some human carriers of severe loss of function alleles. Here, CCNO is linked to Hydrocephalus.